Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors

Journal of Endocrinology

Volumn 173, Issue 1, 2002, Pages 1-11

  McArdle, C A ^a   Franklin, J ^a   Green, L ^a   Hislop, J N ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CALCIUM ION; DYNAMIN; G PROTEIN COUPLED RECEPTOR; GONADORELIN RECEPTOR; GONADOTROPIN; GUANOSINE TRIPHOSPHATASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PHOSPHOLIPASE C;

ADENOVIRUS; ANIMAL CELL; BINDING AFFINITY; BREAST CANCER; CALCIUM MOBILIZATION; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL PROLIFERATION; COATED VESICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; GENETIC TRANSFECTION; GONADOTROPIN RELEASE; HELA CELL; HUMAN; HYPOPHYSIS CELL; INTERNALIZATION; MAMMAL; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE; VIRUS INFECTION; VIRUS RECOMBINANT; XENOPUS;

ANIMALS; ARRESTINS; ENDOCYTOSIS; EVOLUTION, MOLECULAR; GONADOTROPIN-RELEASING HORMONE; HUMANS; MAMMALS; NEOPLASMS; PITUITARY GLAND; PROTEIN BINDING; RECEPTORS, LHRH; SIGNAL TRANSDUCTION; TERMINAL REPEAT SEQUENCES;

EID: 0036241442     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1730001     Document Type: Review

References (69)

1. Clinical application of GnRH and its analogues
2. Role of dynamin, Src, and ras in the protein kinase C-mediated activation of ERK by gonadotrophin-releasing hormone
3. Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotrophin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalisation
4. Gonadotrophin-releasing hormone and its analogs
5. The molecular mechanism of action of gonadotrophin hormone releasing hormone (GnRH) in the pituitary
6. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase
7. Absence of rapid desensitisation of the mouse gonadotrophin-releasing hormone receptor
8. Gonadotrophin-releasing hormone binding sites in human breast carcinoma
9. The use of luteinising hormone releasing hormone agonists and antagonists in gynaecological cancers
10. High affinity binding and direct antiproliferative effects of luteinising hormone-releasing hormone analogs in human endometrial cancer cell lines
11. Growth inhibitory actions of analogues of luteinising hormone releasing hormone on tumour cells
12. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells
13. Oxytocin receptor-mediated activation of phosphoinositidase C and elevation of cytosolic calcium in the gonadotroph-derived alpha T3-1 cell line
14. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in breast cancer cells using recombinant adenovirus
15. Evolving concepts in G-protein-coupled receptor endocytosis: The role in receptor desensitisation and signalling
16. The lack of gonadotrophin-releasing hormone (GnRH) receptor desensitisation in αT3-1 cells is not due to GnRH receptor reserve or phosphatidylinositol 4,5-bis-phosphate pool size
17. Beta arrestin acts as a clathrin adapter in endocytosis of the beta 2 adrenergic receptor
18. Antiproliferative signalling of luteinising hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(1)-mediated activation of phosphotyrosine phosphatase
19. Casein kinase II sites in the intracellular C-terminal domain of the thyrotropin-releasing hormone receptor and chimeric gonadotrophin-releasing hormone receptors contribute to beta-arrestin-dependent internalisation
20. Gonadotrophin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitisation of total inositol phosphate production and exhibit accelerated internalisation kinetics
21. The rat gonadotrophin-releasing hormone receptor internalises via a beta-arrestin-independent, but dynamin-dependent, pathway: Addition of a carboxyl-terminal tail confers beta-arrestin dependency
22. Desensitisation and internalisation of human and xenopus gonadotrophin-releasing hormone receptors expressed in alphaT4 pituitary cells using recombinant adenovirus
23. Differential internalisation of mammalian and non-mammalian gonadotrophin-hormone releasing hormone receptors: Uncoupling of dynamin-dependent internalisation from mitogen-activated protein kinase signalling
24. GnRH receptor and apoptotic signalling
25. Gi protein activation of gonadotrophin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma
26. Intracellular pathways of electron-opaque gonadotrophin-releasing hormone derivatives bound by cultured gonadotrophs
27. Receptor mediated uptake of GnRH agonist and antagonists by cultured gonadotrophs: Evidence for differential intracellular routing
28. Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotrophin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (Dlys6)GnRH and antagonist (Antide)
29. The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary
30. The inhibition of growth and down-regulation of gonadotrophin releasing hormone (GnRH) receptor in alphaT3-1 cells by GnRH agonist
31. Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase
32. Protein-coupled receptors and receptor kinases: From molecular biology to potential therapeutic applications
33. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites
34. The luteinising hormone-releasing hormone receptor in human prostate cancer cells: Messenger ribonucleic acid expression, molecular size, and signal transduction pathway
35. LHRH analogues as anticancer agents: Pituitary and extrapituitary sites of action
36. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds
37. Pituitary adenylate cyclase-activating polypeptide (PACAP) actions on alpha T3-1 gonadotrophs show desensitisation
38. 2+ in the αT3-1 gonadotroph-derived cell line
39. Desensitisation of gonadotrophin-releasing hormone action in the gonadotroph-derived alpha T3-1 cell line
40. 2+ mobilisation
41. The tail of the gonadotrophin-releasing hormone receptor: Desensitisation at, and distal to, G protein-coupled receptors
42. The structure and function of GnRHs and their receptors
43. A novel mammalian receptor for the evolutionarily conserved type II GnRH
44. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signalling and trafficking
45. Growth of human breast cancer cells inhibited by a luteinising hormone-releasing hormone agonist
46. Gonadotrophin-releasing hormone-induced rise in cytosolic free Ca2+ levels: Mobilization of cellular and extracellular Ca2+ pools and relationship to gonadotrophin secretion
47. Activation of MAPK cascades by G-protein-coupled receptors: The case of gonadotrophin-releasing hormone receptor
48. Potential regulatory roles for G protein-coupled receptor kinases and beta-arrestins in gonadotrophin-releasing hormone receptor signaling
49. High efficiency method for gene transfer in normal pituitary gonadotropes: Adenoviral-mediated expression of G protein-coupled receptor kinase 2 suppresses luteinizing hormone secretion
50. A gonadotrophin-releasing hormone (GnRH) receptor specific for GnRH II in primates
51. A new form of the GnRH receptor (h-GnRH-R II) is encoded in the human genome, expressed by the pituitary, and resembles the type II GnRH-R of non-mammals
52. LH-RH analogues: I. Their impact on reproductive medicine
53. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
54. Dynamin and its partners: A progress report
55. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: Activation of two signal transduction pathways in the gonadotrope-derived αT3-1 cell line
56. Molecular mechanisms of ligand interaction with the gonadotrophin-releasing hormone receptor
57. Expression and signal transduction pathways of gonadotrophin-releasing hormone receptors
58. A chicken gonadotrophin-releasing hormone receptor that confers agonist activity to mammalian antagonists. Identification of D-Lys(6) in the ligand and extracellular loop two of the receptor as determinants
59. Stimulus-dependent phosphorylation of G-protein-coupled receptors by casein kinase 1 alpha
60. Complementary deoxyribonucleic acid cloning, gene expression, and ligand selectivity of a novel gonadotrophin-releasing hormone receptor expressed in the pituitary and midbrain of Xenopus laevis
61. Control of EGF receptor signalling by clathrin-mediated endocytosis
62. Agonist-induced endocytosis and recycling of the gonadotrophin-releasing hormone receptor: Effect of beta-arrestin on internalisation kinetics
63. Acute desensitisation of phospholipase C-coupled muscarinic M3 receptors but not gonadotrophin-releasing hormone receptors co-expressed in alpha T3-1 cells: Implications for mechanisms of rapid desensitisation
64. Lack of a C-terminal tail in the mammalian gonadotrophin-releasing hormone receptor confers resistance to agonist-dependent phosphorylation and rapid desensitisation
65. 2+ responses in alpha T3-1 gonadotrophs
66. Degradation of inositol 1,4,5-trisphosphate receptors during cell stimulation is a specific process mediated by cystein protease activity
67. Molecular mechanisms of G protein-coupled receptor signalling: Role of G protein-coupled receptor kinases and arrestins in receptor desensitisation and resensitization
68. Activation of mitogen-activated protein kinase phosphatase 2 by gonadotrophin-releasing hormone
69. Ligand binding directly stimulates ubiquitinylation of the inositol 1,4,5-trisphosphate receptor